摘要
Abstract
Objective To explore the application of Chinese patent medicine injection before and after the clinical pharmacist interven-tion,to ensure the safety of clinical medicine. Methods 3 021 pieces of prescription after 2-4 months after intervention were selected as the study group,and 2 800 pieces of prescription from January to March 2014 before the intervention were selected as the control group. The levels of prescription application of the two groups were compared. Results After clinical pharmacist intervention,the rate of non-standard application was 4. 79%,which was significantly lower than 32. 70% before the intervention (χ2=8. 12,P < 0. 05);the main problems existing in the application of Chinese patent medicine injection were selection of solvent,solvent dosage discomfort and drug dosage discomfort. Before the intervention,selection of solvent discomfort was 14 pieces,the amount of solvent discomfort was 35 pieces,drug dosage discomfort was 3 pieces,while after clinical pharmacists′ intervention,the numbers were 1,6,2 pieces respectively, which was significantly less than before intervention (χ2=4. 98,10. 02,6. 12,P < 0. 05);the Chinese patent medicine injections that were in the non-standard prescriptions involved 8 drugs before intervention,while after clinical pharmacist intervention,the number was only 3,and the non-standard usage rate of Danhong Injection decreased obviously(χ2=3. 21,P < 0. 05). Conclusion Clinical phar-macists play a key role in the rational drug use of the hospita′s outpatient Chinese patent medicine injections,and the standard rate of drugs significantly improved after the intervention.关键词
合理用药/中成药/门诊/注射剂/临床药师Key words
rational drug use/Chinese patent medicine/outpatient/injection/clinical pharmacists分类
药学
